靶向肿瘤坏死因子超家族的死亡受体和诱饵受体 - Suppr

Suppr

超能文献

Targeting death and decoy receptors of the tumour-necrosis factor superfamily.

作者信息

Ashkenazi Avi

机构信息

Department of Molecular Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, USA.

出版信息

Nat Rev Cancer. 2002 Jun;2(6):420-30. doi: 10.1038/nrc821.

DOI:10.1038/nrc821

PMID:12189384

Abstract

摘要

相似文献

Targeting death and decoy receptors of the tumour-necrosis factor superfamily.

Nat Rev Cancer. 2002 Jun;2(6):420-30. doi: 10.1038/nrc821.

Cheating death: what can we learn from tumour resistance?

Cell Death Differ. 2004 Jul;11 Suppl 1:S8-9. doi: 10.1038/sj.cdd.4401463.

Modulation of death receptor signalling.

Symp Soc Exp Biol. 2000;52:31-42.

Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity.

Cancer Res. 2005 Oct 15;65(20):9169-75. doi: 10.1158/0008-5472.CAN-05-0939.

Death receptors and melanoma resistance to apoptosis.

Oncogene. 2003 May 19;22(20):3152-61. doi: 10.1038/sj.onc.1206456.

[Death inducing ligands in combination with ionizing radiation: objective and current knowledge].

Strahlenther Onkol. 2003 Mar;179(3):141-51. doi: 10.1007/s00066-003-1047-7.

Targeting death receptors in bladder, prostate and renal cancer.

J Urol. 2006 Feb;175(2):432-8. doi: 10.1016/S0022-5347(05)00160-6.

[Mechanism of programmed cell death (apoptosis)].

Postepy Biochem. 1994;40(3):150-60.

SODD-silencer of death domains.

Stem Cells. 2000;18(5):388-9. doi: 10.1634/stemcells.18-5-388.

Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.

Prostate. 2006 Jun 15;66(9):987-95. doi: 10.1002/pros.20421.

引用本文的文献

Repurposing Rafoxanide: From Parasite Killer to Cancer Fighter.

Biomedicines. 2025 Jul 9;13(7):1686. doi: 10.3390/biomedicines13071686.

Cleavage of CAD by caspase-3 determines the cancer cell fate during chemotherapy.

Nat Commun. 2025 May 30;16(1):5006. doi: 10.1038/s41467-025-60144-2.

Molecular mechanisms of programmed cell death and potential targeted pharmacotherapy in ischemic stroke (Review).

Int J Mol Med. 2025 Jul;56(1). doi: 10.3892/ijmm.2025.5544. Epub 2025 May 9.

Inducing Cancer Cell Killing Using DNA Nanostructure-Mediated Superclustering of Death Receptors.

Nano Lett. 2025 Apr 16;25(15):6310-6317. doi: 10.1021/acs.nanolett.5c01122. Epub 2025 Apr 8.

Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance.

J Hematol Oncol. 2025 Mar 18;18(1):32. doi: 10.1186/s13045-025-01684-4.

Beyond ADCs: harnessing bispecific antibodies to directly induce apoptosis for targeted tumor eradication.

Antib Ther. 2024 Oct 29;7(4):351-360. doi: 10.1093/abt/tbae029. eCollection 2024 Oct.

Turn TRAIL Into Better Anticancer Therapeutic Through TRAIL Fusion Proteins.

Cancer Med. 2025 Jan;14(1):e70517. doi: 10.1002/cam4.70517.

Potential of dehydroepiandrosterone and quercetin to ameliorate copper oxide nanoparticles induced hepatotoxicity in albino wistar rats.

J Mol Histol. 2024 Nov 30;56(1):17. doi: 10.1007/s10735-024-10311-4.

Cellular Senescence and Anti-Aging Strategies in Aesthetic Medicine: A Bibliometric Analysis and Brief Review.

Clin Cosmet Investig Dermatol. 2024 Oct 9;17:2243-2259. doi: 10.2147/CCID.S403417. eCollection 2024.

Apoptosis of Pancreatic Cancer Cells after Co-Treatment with Eugenol and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand.

Cancers (Basel). 2024 Sep 5;16(17):3092. doi: 10.3390/cancers16173092.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Targeting death and decoy receptors of the tumour-necrosis factor superfamily.

作者信息

Ashkenazi Avi

机构信息

Department of Molecular Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, USA.

出版信息

Nat Rev Cancer. 2002 Jun;2(6):420-30. doi: 10.1038/nrc821.

DOI:10.1038/nrc821

PMID:12189384

Abstract

摘要

相似文献

Targeting death and decoy receptors of the tumour-necrosis factor superfamily.

Nat Rev Cancer. 2002 Jun;2(6):420-30. doi: 10.1038/nrc821.

Cheating death: what can we learn from tumour resistance?

Cell Death Differ. 2004 Jul;11 Suppl 1:S8-9. doi: 10.1038/sj.cdd.4401463.

Modulation of death receptor signalling.

Symp Soc Exp Biol. 2000;52:31-42.

Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity.

Cancer Res. 2005 Oct 15;65(20):9169-75. doi: 10.1158/0008-5472.CAN-05-0939.

Death receptors and melanoma resistance to apoptosis.

Oncogene. 2003 May 19;22(20):3152-61. doi: 10.1038/sj.onc.1206456.

[Death inducing ligands in combination with ionizing radiation: objective and current knowledge].

Strahlenther Onkol. 2003 Mar;179(3):141-51. doi: 10.1007/s00066-003-1047-7.

Targeting death receptors in bladder, prostate and renal cancer.

J Urol. 2006 Feb;175(2):432-8. doi: 10.1016/S0022-5347(05)00160-6.

[Mechanism of programmed cell death (apoptosis)].

Postepy Biochem. 1994;40(3):150-60.

SODD-silencer of death domains.

Stem Cells. 2000;18(5):388-9. doi: 10.1634/stemcells.18-5-388.

Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.

Prostate. 2006 Jun 15;66(9):987-95. doi: 10.1002/pros.20421.

引用本文的文献

Repurposing Rafoxanide: From Parasite Killer to Cancer Fighter.

Biomedicines. 2025 Jul 9;13(7):1686. doi: 10.3390/biomedicines13071686.

Cleavage of CAD by caspase-3 determines the cancer cell fate during chemotherapy.

Nat Commun. 2025 May 30;16(1):5006. doi: 10.1038/s41467-025-60144-2.

Molecular mechanisms of programmed cell death and potential targeted pharmacotherapy in ischemic stroke (Review).

Int J Mol Med. 2025 Jul;56(1). doi: 10.3892/ijmm.2025.5544. Epub 2025 May 9.

Inducing Cancer Cell Killing Using DNA Nanostructure-Mediated Superclustering of Death Receptors.

Nano Lett. 2025 Apr 16;25(15):6310-6317. doi: 10.1021/acs.nanolett.5c01122. Epub 2025 Apr 8.

Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance.

J Hematol Oncol. 2025 Mar 18;18(1):32. doi: 10.1186/s13045-025-01684-4.

Beyond ADCs: harnessing bispecific antibodies to directly induce apoptosis for targeted tumor eradication.

Antib Ther. 2024 Oct 29;7(4):351-360. doi: 10.1093/abt/tbae029. eCollection 2024 Oct.

Turn TRAIL Into Better Anticancer Therapeutic Through TRAIL Fusion Proteins.

Cancer Med. 2025 Jan;14(1):e70517. doi: 10.1002/cam4.70517.

Potential of dehydroepiandrosterone and quercetin to ameliorate copper oxide nanoparticles induced hepatotoxicity in albino wistar rats.

J Mol Histol. 2024 Nov 30;56(1):17. doi: 10.1007/s10735-024-10311-4.

Cellular Senescence and Anti-Aging Strategies in Aesthetic Medicine: A Bibliometric Analysis and Brief Review.

Clin Cosmet Investig Dermatol. 2024 Oct 9;17:2243-2259. doi: 10.2147/CCID.S403417. eCollection 2024.

Apoptosis of Pancreatic Cancer Cells after Co-Treatment with Eugenol and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand.

Cancers (Basel). 2024 Sep 5;16(17):3092. doi: 10.3390/cancers16173092.